Searched for
SHAPE PHARMA
How India can win in a rewired global economyIndia is poised to gain from global supply chain shifts. Strategic neutrality and domestic focus are key. The nation must build robust buff...- Light at the end of the tunnel? Gautam Shah sees Nifty eyeing 25,500, bets on smallcaps, pharma and Adani stocksIndian equities are nearing a crucial turning point, with market veteran Gautam Shah suggesting a shift in focus beyond benchmark indices. ...
- Ahead of Market: 10 things that will decide stock market action on MondayMarkets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
- We want to foster peace, stability for people of Afghanistan: MEA reaffirms India's commitment to Afghan developmentIndia continues its strong support for Afghanistan, reaffirms MEA. The nation is focused on peace, stability, and development. This include...
- Trade pact with Oman strengthens India's energy security: ExpertsThe recent trade accord between India and Oman represents a significant leap toward energy independence and economic integration. Experts n...
- FII exodus, crude shock, and Rupee under pressure: Deepak Shenoy breaks down India's market stormIndian stock markets are facing tough times due to global economic factors. Deepak Shenoy of Capitalmind MF advises investors to look beyon...
- Pankaj Pandey identifies defence, pharma and consumption as core stock picking themesIndian equities face a mixed outlook due to potential monsoon deficit and uneven corporate earnings. While rural-linked sectors may see pre...
- ETMarkets PMS Talk | A 'private equity approach' to public markets has driven our investing success for 15 years: Sameer ShahValueQuest's Sameer Shah champions a private equity approach to public markets. He focuses on deep research and conviction in identifying t...
- June quarter earnings to determine market direction, says Sunil Subramaniam, warns on risks in near termMarket expert Sunil Subramaniam advised caution amid geopolitical uncertainty and rising input costs, while favouring consumer durables, ca...
- PM Narendra Modi and PM Giorgia Meloni outline Indo-Mediterranean vision to deepen India-Italy tiesIndia and Italy are shaping an Indo-Mediterranean partnership focused on trade, AI, defence, clean energy and connectivity, with Narendra M...
- 'Fear of trolling stopping Indians from trying': UPSC mentor sparks debate after Saurabh Dwivedi's Kartavya Netflix debut goes viralJournalist Saurabh Dwivedi's acting debut in Netflix's 'Kartavya' sparked online mockery, igniting a debate on India's culture of online ri...
- Sensex dips 3,400 points in 4 days. Is this the beginning of a bigger crash?Indian equity markets fell for a fourth straight session as rising crude oil prices, geopolitical tensions, FII selling, and a record-low r...
- As US reboots psychedelics from counterculture to R&D, Indian pharma must take the leadThe United States is accelerating research into psychedelic drugs for mental illness. This shift prompts India to re-evaluate its own drug ...
- How AI Innovation and Artificial Intelligence products are transforming global industriesAs innovation evolves beyond industry boundaries, the AI Special Product / Innovation category at the ET Most Innovative AI Product Awards ...
- ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- When the world's an oyster for Sun (Pharma)Indian companies are increasingly making bold acquisitions abroad. Sun Pharma's deal signals a new era of deliberate empire-building. This ...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
Load More
